The safety and efficacy of a cosmetic camouflaging agent for post‐procedural bruising.

Introduction: A challenge of minimally invasive esthetic procedures (eg, injectables and threads) is managing adverse events (AEs), such as post‐procedural bruising. Implementation of post‐procedural camouflage therapy may minimize the appearance of bruising and mitigate AEs. Aims: A physician and patient user experience program was designed to evaluate the safety and efficacy of a concealer for the cosmetic camouflage of post‐procedural bruising. Methods: Thirty female patients with a mean age of 42.03 years participated in the program. Physicians and patients completed various questionnaires regarding the safety and efficacy of the investigational product (Dermablend™ Professional Cover Care Full Coverage Concealer) at three timepoints: Visit 1 (Day 0); Visit 2 (Day 3); and Visit 3 (Day 14 ± 3 days). Results: All patients presented with mild‐to‐moderate bruising following treatment with either esthetic injectables or threads. On average, users required 1.55 (SD: 0.72) coats to sufficiently cover their bruise(s). After application of the concealer, 78.18% of users displayed "clear skin with no signs of erythema" and 21.82% displayed "almost clear skin, with slight redness." No physician‐reported AEs related to product use were reported throughout the evaluation period. No allergic reactions upon application nor intolerance to the product after prolonged use (ie, up to 14 days ± 3 days) was observed. Throughout the duration of use, 98.81% of subjects were at least slightly satisfied with results. At Visits 1 and 2, 100% of physicians were at least slightly satisfied with results. Conclusion: Cosmetic concealer use can ameliorate the post‐procedural experience for patients presenting with mild‐to‐moderate bruising. [ABSTRACT FROM AUTHOR]